Meetings
The Society for Experimental Biology and Medicine holds an annual member's meeting in conjunction
with the EB meetings each year.
SEBM Symposium
Experimental Biology 2013
New Experimental Approaches to Human Brain Function in Health and Disease
| Chair: | |
| Michael J. Friedlander, PhD, Virginia Tech Carilion Research Institute |
|
Positron Emission Tomography: A Tool to Explore Pathophysiology and to Facilitate Therapeutic Drug Development Robert B. Innis, MD, PhD, National Institute of Mental Health |
|
|
Sub-second Measurements of Dopamine in Human Brain and Their Correlation with Decision Variables P. Read Montague, PhD, Virginia Tech Carilion Research Institute and the Wellcome Trust Centre for Neuroimaging, University College London |
|
|
Epistatic Interactions of AKT1 on Human Medial Temporal Lobe Biology and Pharmacogenetic Implications Daniel R. Weinberger, MD, Johns Hopkins University |
|
|
Genomic Duplication Predisposes to Disease Risk and Mediates Gene Innovations During Human Evolution Evan E. Eichler, PhD, Howard Hughes Medical Institute, University of Washington |
SEBM Symposium
Experimental Biology 2012
Stem Cell Biology 2012: Basic Science and Translational Advances
| Chairs: | Martin L. Adamo, PhD, University of Texas HSC San Antonio |
| Michael J. Friedlander, PhD, Virginia Tech Carilion Research Institute |
|
Nonhuman Primate Induced Pluripotent Stem Cells in Regenerative Medicine Peter Hornsby, PhD, University of Texas HSC, San Antonio |
|
|
Generation of Clinically-Compliant Dopaminergic Neurons from Pluripotent Stem Cells for Parkinson’s
Disease Therapy Xianmin Zeng, PhD, Buck Institute for Research on Aging |
|
|
Use of Stem Cells for Islet Regeneration in Diabetes Rohit Kulkarni, MD, PhD, Joslin Diabetes Center |
|
|
Tissue-specific Stem Cells in Aging and Cancer Amy Wagers, PhD, Joslin Diabetes Center |
SEBM Symposium at EB 2011
Energy Metabolism and the Pathogenesis, Treatment and Prevention of Obesity and Diabetes
Chairs: Martin L. Adamo, University of Texas HSC at San Antonio and David M. Kendall, American Diabetes Association
"Changes in Fuel Selection in Chronic Metabolic Diseases Revealed by Comprehensive Metabolic Profiling"
Christopher B. Newgard, PhD, Duke University Medical Center
"AMPK and AMPK Related Kinases: Critical Regulators of Energy Metabolism"
Laurie Goodyear, PhD Joslin Diabetes Center
"Pathophysiology of Type 2 Diabetes: Implications for Therapy"
Franco Folli, MD, PhD, University of Texas HSC at San Antonio
"Why Should We Train Clinicians in Systems Biology"?
David M. Kendall, MD American Diabetes Association
SEBM Symposium at EB 2010
Evolving from Reductionism to Holism: The Future is Systems Medicine
Chairs: Susan E. Mulroney, Georgetown University and Howard Federoff, Georgetown University
"Systems Medicine and the Emergence of Proative Medicine - Predictive, Personalized, Preventive and Participatory"
Lee Hood, MD, PhD, Institute for Systems Biology
"A Systems Medicine Approach for Neurological Diseases"
Howard Federoff, MD, PhD, Georgetown University Medical Center
"A Systems Medicine Approach to Treating Cancer"
Michael Cusick, PhD, Dana Farber Cancer Institute, Havard University
"Why Should We Train Clinicians in Systems Biology"?
Robert Clarke, PhD, Georgetown University
"Legan, Ethical and Policy Implications of Systems Medicine"
Elenora E. Connors, JD, MPH, O'Neill Institute for National and Global Health Law, Georgetown University Law School
SEBM Symposium at EB 2009
The Co-morbidity of Stress and Disease: Effects of Chronic Stress on Metabolism, Cardiovascular Disease and Behavior
Chairs: Susan E. Mulroney, Georgetown University and Yvette Tache, UCLA
"Corticotropin-Releasing Hormone and Stress-Related Disease"
Yvette Tache, PhD, David Geffen School of Medicine, UCLA
"Chronic stress exacerbates development of metabolic syndrome via an NPY-mediated mechanism"
Zofia Zukowska, MD, PhD, Georgetown University Medical Center
"Stress and anxiety"
Annika Thorsell, PhD, Staff Scientist, NIH/NIAA
"Adaptation to Extreme Stress: Neuropeptide Y, PTSD, and Long-term Health Consequences"
Ann Rasmusson, MD, Yale University and VA National Center for PTSD
SEBM Symposium at EB 2008, San Diego, California
"Progress in Pharmacogenomics and Its Promise for Medicine"
Chairs: Burton E. Sobel, University of Vermont and Charles A. Blake, University of South Carolina
"Implications of Pharmocogenomics for Drug Development"
Randal J. Kirk, J.D., CEO, Third Security, LLC
"Implications of pharmacogenomics requiring regulatory agency"
Mary K. Pendergast, J.D., L.L.M, Pendergast Consulting, Washington, DC
"Applications of pharmacogenomics in the use of psychotropic drugs"
Meeta Patnaik, M.D., Senior Vice President, Predictive Diagnostics Development for PGxHealth
"Pharmaco-proteomic approaches to understanding the mechanisms and side effects of sickle cell drug therapy"
Steven R. Goodman, PhD, Editor-in-Chief, Experimental Biology and Medicine, University of Texas at Dallas
SEBM Symposium at EB 2007, Washington D.C.
"Nanotechnology, Biology, and Medicine in SEBM's Second Century"
SEBM gratefully acknowledges Genentech for their donation in support of this symposium.
Chairs: Burton E. Sobel, University of Vermont and Charles A. Blake, University of South Carolina
"Engineered viruses for biomedical science"
M.G. Finn, The Scripps Research Institute
"Biological structures of mesosclae systems"
Stephen G. Sligar, University of Illinois
Experimental biology and medicine" in SEBM's second century
Steven R. Goodman, University of Texas at Dallas
SEBM Symposium at EB 2006, San Francisco
"The Role of Modern Biology and Medicine in Drug Development in Academia and Industry"
Chairpersons: Charles A.Blake, University of South Carollina and Kenneth L. Barker, State University of New York, Syracuse
Ted W. Love, Nuvelo, Inc.
"How to Attract the Best and Brightest to Benefit Drug Development"
Timothy P. Clackson, ARIAD Pharmaceuticals, Inc
"Translational Research In Academia and Industry"
Scott P. Kennedy, Pfizer Gobal R&D
"Effective Partnering of Academic and Physician Scientistswith the Pharmaceutical Drug Development Industry"
Discussion Leader: Burton E. Sobel, University of Vermont
SEBM Symposium at EB 2005, San Diego
"Physiological Proteomics"
Chairpersons: Charles A. Blake and Steven R. Goodman
Charles A. Blake, University of South Carolina
"The proteomics of the anterior pituitary gland"
Steven R. Goodman, University of of Texas at Dallas
"The proteomics of sickle cell disease"
Carlos Gusti Gartner, Harvard Medical School
"Catch-and-release (CAR) reagents: new tools for broadscale analysis of the proteome"
Mark W. Duncan, Univeristy of Colorado Health Sciences Center
"Clinical applications of proteomics"
SEBM Symposium at EB 2004, Washington, DC
Support for this symposium has been provided by AstraZeneca
"Non-hemostatic Physiological Effects of Hemostatis-related Components"
Organized and Chaired by: Kenneth L. Barker, PhD, Upstate Medical University, Syracuse, New York
David J. Loskutoff, Scripps Research Institute
"Role of PAI-1 in Cell Adhesion and Detachment"
Daniel A. Lawrence, American Red Cross Holland Laboratories
"Fibrinolytic Molecules and Neural Function"
Jay L. Degen, Children's Hospital Research Foundation, Cincinnati
"Dissociation of the Hemostatic and Inflammatory Roles of Fibrinogen"
Jerry Ware, Scripps Clinic
"Septins in Platelets and Neural Tissue"
SEBM Symposium at EB 2003, San Diego
Support for this symposium has been provided by Merck & Co and AstraZeneca.
"Career Planning for Experimental Biology, Biomedical and Physician Scientists"
Organized and Chaired by: Kenneth L. Barker, PhD, Upstate Medical University, Syracuse, New York
"Physician-Scientists: Preparation, Opportunities, and National Need"
Kenneth Kaushansky, MD, University of California at San Diego
Biological Scientists in Industry: What Companies Need and Their Criteria for Selection of Professional Scientific Staff"
William T. Schrader, PhD, Schrader Biotech Consulting, Inc
"Building and Supporting Effective Academic Clinical Research Programs in Today's Market-driven Health Care Environment"
Kenneth L. Barker, PhD, Upstate Medical University, New York
"Balancing the Competing Career Demands of the Academic Physician-Scientist: Personal Challenges and Rewards"
Mary Sue O'Dorisio, MD, PhD, University of Iowa
